Education
About Us
Working with TipRanks
Follow Us
Rapid Therapeutic Science Laboratories (RTSL)
OTHER OTC:RTSL
RTSL Stock Chart & Stats
<$0.01
<$0.01(100.00%)
At close: 4:00 PM EST
<$0.01
<$0.01(100.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume930.00
Average Volume (3M)N/A
Market Cap
$52.99K
Enterprise Value$3.50M
Total Cash (Recent Filing)$2.16K
Total Debt (Recent Filing)$3.79M
Price to Earnings (P/E)―
Beta-5.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding8,832,251
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-1.85
Price to Sales (P/S)0.00
P/FCF Ratio-4.88
Enterprise Value/Market Cap66.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-7.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RTSL FAQ
What was Rapid Therapeutic Science Laboratories’s price range in the past 12 months?
Currently, no data Available
What is Rapid Therapeutic Science Laboratories’s market cap?
Rapid Therapeutic Science Laboratories’s market cap is $52.99K.
When is Rapid Therapeutic Science Laboratories’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rapid Therapeutic Science Laboratories’s earnings last quarter?
Currently, no data Available
Is Rapid Therapeutic Science Laboratories overvalued?
According to Wall Street analysts Rapid Therapeutic Science Laboratories’s price is currently Overvalued.
Does Rapid Therapeutic Science Laboratories pay dividends?
Rapid Therapeutic Science Laboratories does not currently pay dividends.
What is Rapid Therapeutic Science Laboratories’s EPS estimate?
Rapid Therapeutic Science Laboratories’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rapid Therapeutic Science Laboratories have?
Rapid Therapeutic Science Laboratories has 8,832,251 shares outstanding.
What happened to Rapid Therapeutic Science Laboratories’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rapid Therapeutic Science Laboratories?
Currently, no hedge funds are holding shares in RTSL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rapid Therapeutic Science Laboratories
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.
Eason Technology
―
XChange TECINC
―
Lion Group Holding
―
Beneficient
―
Pineapple Financial
―